A novel rat model of gestational diabetes induced by intrauterine programming is associated with alterations in placental signaling and fetal overgrowth

Molecular and Cellular Endocrinology

Volumn 422, Issue , 2016, Pages 221-232

  Capobianco, Evangelina ^a   Fornes, Daiana ^a   Linenberg, Ivana ^a   Powell, Theresa L ^b   Jansson, Thomas ^b   Jawerbaum, Alicia ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Gestational diabetes mellitus; Intrauterine programming; mTOR; Placenta; PPAR

Indexed keywords

GLUCOSE; INITIATION FACTOR 4E BINDING PROTEIN 1; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE C ALPHA; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; MTOR PROTEIN, RAT; PLACENTA PROTEIN; TARGET OF RAPAMYCIN KINASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FETAL OVERGROWTH; FETUS DISEASE; FETUS WEIGHT; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULINEMIA; LIPID PEROXIDATION; LONG TERM EXPOSURE; NONHUMAN; PLACENTA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; DIABETES, GESTATIONAL; FETUS DEVELOPMENT; GENE EXPRESSION REGULATION; METABOLISM; PREGNANCY;

ANIMALS; DIABETES, GESTATIONAL; FEMALE; FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LIPID PEROXIDATION; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; RATS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84956594691     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.12.020     Document Type: Article

References (49)

1. Ashwal E., Hod M. Gestational diabetes mellitus: where are we now?. Clin. Chim. Acta 2015, 451:14-20.
2. Aye I.L., Jansson T., Powell T.L. TNF-alpha stimulates system A amino acid transport in primary human trophoblast cells mediated by p38 MAPK signaling. Physiol. Rep. 2015, 3(10):e12594.
3. Bellamy L., Casas J.P., Hingorani A.D., Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009, 373:1773-1779.
4. Berends L.M., Ozanne S.E. Early determinants of type-2 diabetes. Best. Pract. Res. Clin. Endocrinol. Metab. 2012, 26:569-580.
5. Betz C., Hall M.N. Where is mTOR and what is it doing there?. J. Cell Biol. 2013, 203:563-574.
6. Bracho-Valdes I., Moreno-Alvarez P., Valencia-Martinez I., Robles-Molina E., Chavez-Vargas L., Vazquez-Prado J. mTORC1- and mTORC2-interacting proteins keep their multifunctional partners focused. IUBMB life 2011, 63:896-914.
7. Buchanan T.A., Xiang A.H. Gestational diabetes mellitus. J. Clin. Invest 2005, 115:485-491.
8. Capobianco E., Martinez N., Fornes D., Higa R., Di Marco I., Basualdo M.N., Faingold M.C., Jawerbaum A. PPAR activation as a regulator of lipid metabolism, nitric oxide production and lipid peroxidation in the placenta from type 2 diabetic patients. Mol. Cell Endocrinol. 2013, 377:7-15.
9. Capobianco E., Pelesson M., Careaga V., Fornes D., Canosa I., Higa R., Maier M., Jawerbaum A. Intrauterine programming of lipid metabolic alterations in the heart of the offspring of diabetic rats is prevented by maternal diets enriched in olive oil. Mol. Nutr. Food Res. 2015, 59:1997-2007.
10. Diaz P., Powell T.L., Jansson T. The role of placental nutrient sensing in maternal-fetal resource allocation. Biol. Reprod. 2014, 91:82.
11. Gaccioli F., White V., Capobianco E., Powell T.L., Jawerbaum A., Jansson T. Maternal overweight induced by a diet with high content of saturated fat activates placental mTOR and eIF2alpha signaling and increases fetal growth in rats. Biol. Reprod. 2013, 89:96.
12. Heikamp E.B., Patel C.H., Collins S., Waickman A., Oh M.H., Sun I.H., Illei P., Sharma A., Naray-Fejes-Toth A., Fejes-Toth G., Misra-Sen J., Horton M.R., Powell J.D. The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex. Nat. Immunol. 2014, 15:457-464.
13. Herrera E., Ortega-Senovilla H. Lipid metabolism during pregnancy and its implications for fetal growth. Curr. Pharm. Biotechnol. 2014, 15:24-31.
14. Hiden U., Glitzner E., Hartmann M., Desoye G. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. J. Anat. 2009, 215:60-68.
15. Higa R., Jawerbaum A. Intrauterine effects of impaired lipid homeostasis in pregnancy diseases. Curr. Med. Chem. 2013, 20:2338-2350.
16. Holdsworth-Carson S.J., Lim R., Mitton A., Whitehead C., Rice G.E., Permezel M., Lappas M. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta 2010, 31:222-229.
17. Huopio H., Cederberg H., Vangipurapu J., Hakkarainen H., Paakkonen M., Kuulasmaa T., Heinonen S., Laakso M. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur. J. Endocrinol. 2013, 169:291-297.
18. Jansson N., Rosario F.J., Gaccioli F., Lager S., Jones H.N., Roos S., Jansson T., Powell T.L. Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. J. Clin. Endocrinol. Metab. 2013, 98:105-113.
19. Jansson T., Aye I.L., Goberdhan D.C. The emerging role of mTORC1 signaling in placental nutrient-sensing. Placenta 2012, 33(Suppl. 2):e23-e29.
20. Jansson T., Ekstrand Y., Bjorn C., Wennergren M., Powell T.L. Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes 2002, 51:2214-2219.
21. Jawerbaum A., Capobianco E. Review: effects of PPAR activation in the placenta and the fetus: implications in maternal diabetes. Placenta 2011, 32(Suppl. 2):S212-S217.
22. Jawerbaum A., Capobianco E., Pustovrh C., White V., Baier M., Salzberg S., Pesaresi M., Gonzalez E. Influence of peroxisome proliferator-activated receptor gamma activation by its endogenous ligand 15-deoxy Delta12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. Mol. Hum. Reprod. 2004, 10:671-676.
23. Jawerbaum A., Gonzalez E. Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Curr. Med. Chem. 2006, 13:2127-2138.
24. Jawerbaum A., White V. Animal models in diabetes and pregnancy. Endocr. Rev. 2010, 31:680-701.
25. Kc K., Shakya S., Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann. Nutr. Metabol. 2015, 66(Suppl. 2):14-20.
26. Kim C., Newton K.M., Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25:1862-1868.
27. Kurtz M., Capobianco E., Martinez N., Roberti S., Arany E.J., Jawerbaum A. PPAR ligands improve impaired metabolic pathways in fetal hearts of diabetic rats. J. Mol. Endocrinol. 2014, 53:237-246.
28. Laplante M., Sabatini D.M. Regulation of mTORC1 and its impact on gene expression at a glance. J. Cell Sci. 2013, 126:1713-1719.
29. Lappas M., Hiden U., Desoye G., Froehlich J., Hauguel-de Mouzon S., Jawerbaum A. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid. Redox Signal 2011, 15:3061-3100.
30. Magnusson A.L., Waterman I.J., Wennergren M., Jansson T., Powell T.L. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J. Clin. Endocrinol. Metab. 2004, 89:4607-4614.
31. Martinez N., Kurtz M., Capobianco E., Higa R., White V., Jawerbaum A. PPARalpha agonists regulate lipid metabolism and nitric oxide production and prevent placental overgrowth in term placentas from diabetic rats. J. Mol. Endocrinol. 2011, 47:1-12.
32. Martinez N., Sosa M., Higa R., Fornes D., Capobianco E., Jawerbaum A. Dietary treatments enriched in olive and safflower oils regulate seric and placental matrix metalloproteinases in maternal diabetes. Placenta 2012, 33:8-16.
33. Mrizak I., Grissa O., Henault B., Fekih M., Bouslema A., Boumaiza I., Zaouali M., Tabka Z., Khan N.A. Placental infiltration of inflammatory markers in gestational diabetic women. General Physiol. Biophys. 2014, 33:169-176.
34. Myatt L., Muralimanoharan S., Maloyan A. Effect of preeclampsia on placental function: influence of sexual dimorphism, microRNA's and mitochondria. Adv. Exp. Med. Biol. 2014, 814:133-146.
35. Negre-Salvayre A., Auge N., Ayala V., Basaga H., Boada J., Brenke R., Chapple S., Cohen G., Feher J., Grune T., Lengyel G., Mann G.E., Pamplona R., Poli G., Portero-Otin M., Riahi Y., Salvayre R., Sasson S., Serrano J., Shamni O., Siems W., Siow R.C., Wiswedel I., Zarkovic K., Zarkovic N. Pathological aspects of lipid peroxidation. Free Radic. Res. 2010, 44:1125-1171.
36. Oh W.J., Jacinto E. mTOR complex 2 signaling and functions. Cell Cycle 2011, 10:2305-2316.
37. Pantham P., Aye I.L., Powell T.L. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta 2015, 36:709-715.
38. Perez-Perez A., Maymo J.L., Gambino Y.P., Guadix P., Duenas J.L., Varone C.L., Sanchez-Margalet V. Activated translation signaling in placenta from pregnant women with gestational diabetes mellitus: possible role of leptin. Horm. Metab. Res. 2013, 45:436-442.
39. Pu J., Zhao B., Wang E.J., Nimbal V., Osmundson S., Kunz L., Popat R.A., Chung S., Palaniappan L.P. Racial/Ethnic differences in gestational diabetes prevalence and contribution of common risk factors. Paediatr. Perinat. Epidemiol. 2015, 29:436-443.
40. Roos S., Powell T.L., Jansson T. Placental mTOR links maternal nutrient availability to fetal growth. Biochem. Soc. Trans. 2009, 37:295-298.
41. Rosario F.J., Jansson N., Kanai Y., Prasad P.D., Powell T.L., Jansson T. Maternal protein restriction in the rat inhibits placental insulin, mTOR, and STAT3 signaling and down-regulates placental amino acid transporters. Endocrinology 2011, 152:1119-1129.
42. Rosario F.J., Kanai Y., Powell T.L., Jansson T. Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells. J. Physiol. 2013, 591:609-625.
43. Sasson I.E., Vitins A.P., Mainigi M.A., Moley K.H., Simmons R.A. Pre-gestational vs gestational exposure to maternal obesity differentially programs the offspring in mice. Diabetologia 2015, 58:615-624.
44. Srivastava I.N., Shperdheja J., Baybis M., Ferguson T., Crino P.B. mTOR pathway inhibition prevents neuroinflammation and neuronal death in a mouse model of cerebral palsy. Neurobiol. Dis. 2015, 85:144-154.
45. Wahli W., Michalik L. PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol. Metab. 2012, 23:351-363.
46. Wang Z., Kanguru L., Hussein J., Fitzmaurice A., Ritchie K. Incidence of adverse outcomes associated with gestational diabetes mellitus in low- and middle-income countries. Int. J. Gynaecol. Obstet. 2013, 121:14-19.
47. White V., Jawerbaum A., Mazzucco M.B., Gauster M., Desoye G., Hiden U. Diabetes-associated changes in the fetal insulin/insulin-like growth factor system are organ specific in rats. Pediatr. Res. 2015, 77:48-55.
48. Yin W., Naini S.M., Chen G., Hentschel D.M., Humphreys B.D., Bonventre J.V. Mammalian target of rapamycin mediates kidney injury molecule 1-Dependent tubule injury in a surrogate model. J. Am. Soc. Nephrol. November 4, 2015, JASN November 4, 2015 ASN.2015050500. 10.1681/ASN.2015050500.
49. Zambrano E., Nathanielsz P.W. Mechanisms by which maternal obesity programs offspring for obesity: evidence from animal studies. Nutr. Rev. 2013, 71(Suppl. 1):S42-S54.